These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28784453)

  • 1. Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus.
    Zellweger MJ; Haaf P; Maraun M; Osterhues HH; Keller U; Müller-Brand J; Jeger R; Pfister O; Brinkert M; Burkard T; Pfisterer M;
    Int J Cardiol; 2017 Oct; 244():37-42. PubMed ID: 28784453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy.
    Zellweger MJ; Maraun M; Osterhues HH; Keller U; Müller-Brand J; Jeger R; Pfister O; Burkard T; Eckstein F; von Felten S; Osswald S; Pfisterer M
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):1001-10. PubMed ID: 25240454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of risk factors and asymptomatic carotid atherosclerosis in diabetic patients screened for silent myocardial ischemia by SPECT myocardial imaging.
    Mitevska IP; Baneva N; Bosevski M; Kostovska ES
    Nucl Med Rev Cent East Eur; 2017; 20(1):3-9. PubMed ID: 28198536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of myocardial perfusion scintigraphy in asymptomatic patients with diabetes mellitus at high cardiovascular risk: 5-year follow-up of the prospective multicenter BARDOT trial.
    Caobelli F; Haaf P; Haenny G; Pfisterer M; Zellweger MJ;
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3512-3521. PubMed ID: 33884468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life as predictor for the development of cardiac ischemia in high-risk asymptomatic diabetic patients.
    Haaf P; Ritter M; Grize L; Pfisterer ME; Zellweger MJ;
    J Nucl Cardiol; 2017 Jun; 24(3):772-782. PubMed ID: 28091969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Usefulness of Cardiac Stress Test Modalities in Patients With Type 2 Diabetes Mellitus Who Underwent Myocardial Perfusion Scintigraphy (from the Basel Asymptomatic High-Risk Diabetics' Outcome Trial).
    Caobelli F; Haaf P; Chronis J; Haenny G; Brinkert M; Pfisterer ME; Zellweger MJ;
    Am J Cardiol; 2017 Oct; 120(7):1098-1103. PubMed ID: 28807404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy.
    Prior JO; Monbaron D; Koehli M; Calcagni ML; Ruiz J; Bischof Delaloye A
    Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):60-9. PubMed ID: 15309331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients.
    Zellweger MJ; Hachamovitch R; Kang X; Hayes SW; Friedman JD; Germano G; Pfisterer ME; Berman DS
    Eur Heart J; 2004 Apr; 25(7):543-50. PubMed ID: 15120050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of "routine" cardiac stress imaging 5 years after percutaneous coronary intervention: the prospective long-term observational BASKET (Basel Stent Kosteneffektivitäts Trial) LATE IMAGING study.
    Zellweger MJ; Fahrni G; Ritter M; Jeger RV; Wild D; Buser P; Kaiser C; Osswald S; Pfisterer ME;
    JACC Cardiovasc Interv; 2014 Jun; 7(6):615-21. PubMed ID: 24835324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT.
    Shaw LJ; Wilson PW; Hachamovitch R; Hendel RC; Borges-Neto S; Berman DS
    JACC Cardiovasc Imaging; 2010 Nov; 3(11):1139-48. PubMed ID: 21071002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transthoracic echocardiographic abnormalities in asymptomatic diabetic patients: association with microalbuminuria and silent coronary artery disease.
    Nguyen MT; Cosson E; Valensi P; Poignard P; Nitenberg A; Pham I
    Diabetes Metab; 2011 Sep; 37(4):343-50. PubMed ID: 21398163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of myocardial perfusion scintigraphy for patients suspected of and diagnosed with coronary artery disease.
    Zorga P; Birkenfeld B; Listewnik MH; Piwowarska-Bilska H
    Nucl Med Rev Cent East Eur; 2012 Apr; 15(1):14-21. PubMed ID: 23047568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors accounting for true silent myocardial ischemia: a pilot case-control study comparing type 2 diabetic with non-diabetic control subjects.
    Hernández C; Candell-Riera J; Ciudin A; Francisco G; Aguadé-Bruix S; Simó R
    Cardiovasc Diabetol; 2011 Jan; 10():9. PubMed ID: 21255408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients.
    Cosson E; Nguyen MT; Pham I; Pontet M; Nitenberg A; Valensi P
    Diabet Med; 2009 Sep; 26(9):872-9. PubMed ID: 19719707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary computed tomographic angiographic findings in asymptomatic patients with type 2 diabetes mellitus.
    Park GM; Lee SW; Cho YR; Kim CJ; Cho JS; Park MW; Her SH; Ahn JM; Lee JY; Park DW; Kang SJ; Kim YH; Lee CW; Koh EH; Lee WJ; Kim MS; Lee KU; Kang JW; Lim TH; Park SW; Park SJ; Park JY
    Am J Cardiol; 2014 Mar; 113(5):765-71. PubMed ID: 24528613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of J-ACCESS 4: prognostic impact of reducing myocardial ischemia identified using ECG-gated myocardial perfusion SPECT in Japanese patients with coronary artery disease.
    Nanasato M; Nakajima K; Fujita H; Zen K; Kohsaka S; Hashimoto A; Moroi M; Fukuzawa S; Chikamori T; Nishimura S; Yamashina A; Kusuoka H; Hirayama A; Nishimura T
    J Cardiol; 2014 Feb; 63(2):159-64. PubMed ID: 24012330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive detection of silent coronary artery disease in patients with essential hypertension, alone or associated with type 2 diabetes mellitus, using dipyridamole stress 99mtechnetium-sestamibi myocardial perfusion imaging.
    Lacourcière Y; Côté C; Lefebvre J; Dumont M
    Can J Cardiol; 2006 Feb; 22 Suppl A():16A-21A. PubMed ID: 16485055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow-mediated-paradoxical vasoconstriction is independently associated with asymptomatic myocardial ischemia and coronary artery disease in type 2 diabetic patients.
    Nguyen MT; Pham I; Valensi P; Rousseau H; Vicaut E; Laguillier-Morizot C; Nitenberg A; Cosson E
    Cardiovasc Diabetol; 2014 Jan; 13():20. PubMed ID: 24428877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microalbuminuria predicts silent myocardial ischaemia in type 2 diabetes patients.
    Giovacchini G; Cappagli M; Carro S; Borrini S; Montepagani A; Leoncini R; Mazzotta G; Sambuceti G; Mariani G; Volterrani D; Zellweger MJ; Ciarmiello A
    Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):548-57. PubMed ID: 23314258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis by coronary computed tomographic angiography: matched comparison with myocardial perfusion single-photon emission computed tomography.
    Shaw LJ; Berman DS; Hendel RC; Borges Neto S; Min JK; Callister TQ
    J Cardiovasc Comput Tomogr; 2008; 2(2):93-101. PubMed ID: 19083928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.